Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind Comparative Trial and Open-Label Extension Trial to Investigate the Safety and Efficacy of TW-012R in Alzheimer's Disease With Presenilin 1 (PSEN1) Mutations

NCT04413344 is registered in ClinicalTrials.gov with Kyoto University as lead sponsor.

NCT NCT04413344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04413344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind Comparative Trial and Open-Label Extension Trial to Investigate the Safety and Efficacy of TW-012R in Alzheimer's Disease With Presenilin 1 (PSEN1) Mutations
Lead sponsor
Kyoto University
Phase
Phase 1/2
Overall status
Completed
Start date
June 5, 2020
Completion date
November 24, 2021
Enrollment
8 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

familial alzheimer disease (fad), psen1 mutation